Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | The value of the early relapse EBMT score in multiple myeloma

In this video, Meral Beksac, MD, Istinye University Ankara Liv Hospital, Ankara, Turkey, shares some insights into the recently published early relapse EBMT score for patients with multiple myeloma. This score incorporates several factors, including ISS, patient-related factors, and treatment-related factors to improve relapse prediction in this patient population. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.